Clinical Trial Update: UCN-01 in Treating Patients With Advanced or Metastatic Kidney Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update of UCN-01 in patients with advanced or metastatic renal cell carcinoma (kidney cancer) sponsored by UCSF.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• UCN-01 (7-hydroxystaurosporine)

Snippet

Sponsor: University of California, San Francisco | Conditions: Kidney Cancer | Phase 2 | Status: UNKNOWN